Unconfigured Ad
Collapse
Bridged amplification & clustering followed by sequencing by synthesis.
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by kbkubow, 02-06-2026, 07:12 AM
|
8 responses
317 views
0 reactions
|
Last Post
by kbkubow
07-23-2026, 05:29 AM
|
||
|
Started by tweakyaustin, 08-29-2025, 02:50 AM
|
3 responses
304 views
0 reactions
|
Last Post
by GenCenOrange
01-16-2026, 09:03 AM
|
||
|
Started by ajthomas, 05-20-2025, 11:08 AM
|
6 responses
691 views
0 reactions
|
Last Post
by Gmurray90
01-15-2026, 02:39 AM
|
||
|
Started by CHRIS BILI, 12-02-2025, 05:14 AM
|
1 response
127 views
0 reactions
|
Last Post
by lilou
12-16-2025, 12:48 PM
|
||
|
Started by MehmetZeki, 02-04-2025, 10:27 AM
|
2 responses
475 views
0 reactions
|
Last Post
by DM Hagan
11-24-2025, 10:19 AM
|
||
|
Sequencing a CO1 metabarcoding library on Illumina MiSeq using spike in of custom primers leads to only PhiX reads
by kbkubow
Started by kbkubow, 08-08-2024, 05:14 AM
|
4 responses
352 views
0 reactions
|
Last Post
by tweakyaustin
08-29-2025, 02:55 AM
|
||
|
Started by cement_head, 08-15-2025, 04:08 AM
|
1 response
200 views
0 reactions
|
Last Post
by seqadmin
08-15-2025, 11:49 AM
|
||
|
Started by nargesd, 06-29-2025, 03:46 AM
|
2 responses
303 views
0 reactions
|
Last Post
by nargesd
07-27-2025, 05:52 AM
|
||
|
Started by Constanza Muñoz, 09-20-2022, 12:56 PM
|
2 responses
293 views
0 reactions
|
Last Post
|
||
|
Started by Farshid, 04-26-2025, 12:38 AM
|
1 response
115 views
0 reactions
|
Last Post
by ehaag
07-08-2025, 12:38 PM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 07:41 AM
|
0 responses
9 views
0 reactions
|
Last Post
by SEQadmin2
Today, 07:41 AM
|
||
|
Started by SEQadmin2, 08-03-2026, 10:13 AM
|
0 responses
22 views
0 reactions
|
Last Post
by SEQadmin2
08-03-2026, 10:13 AM
|
||
|
Started by SEQadmin2, 07-31-2026, 02:55 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
07-31-2026, 02:55 AM
|